Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-06-04

Clinical Trial Update: Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating adjuvant toremifene with or without goserelin in premenopausal women with Stage I-IIIA hormone receptor-positive breast cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Goserelin (Goserelin)
  • Toremifene (toremifene)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer, Chemotherapy Induced Amenorrhea | Phase 3 | Status: UNKNOWN